2019 annual financial data
BioCryst Pharmaceuticals 2019 Operating margin
BioCryst Pharmaceuticals 2019 operating margin with verified reported values.
Direct answer
Operating margin was -203.66%.
Operating income was -99,455,000 USD and net income was -108,897,000 USD.
Operating cash flow was -89,584,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,835,000 USD
- Operating income
- -99,455,000 USD
- Net income
- -108,897,000 USD
- Operating cash flow
- -89,584,000 USD